ChemBriefEvonik Hones Growth Strategy, Secures Investments from Efficiency Program
Evonik announced a restructuring plan cutting 3,200 jobs and divesting assets to fund growth in healthcare and biotechnology, raising its 2026 EBITDA guidance to €2.0 billion-2.2 billion. It plans to
icis · 2026-09-22 00:00 UTC